![Endocrines | Free Full-Text | Maturity-Onset Diabetes of the Young (MODY): Genetic Causes, Clinical Characteristics, Considerations for Testing, and Treatment Options Endocrines | Free Full-Text | Maturity-Onset Diabetes of the Young (MODY): Genetic Causes, Clinical Characteristics, Considerations for Testing, and Treatment Options](https://www.mdpi.com/endocrines/endocrines-02-00043/article_deploy/html/images/endocrines-02-00043-g001.png)
Endocrines | Free Full-Text | Maturity-Onset Diabetes of the Young (MODY): Genetic Causes, Clinical Characteristics, Considerations for Testing, and Treatment Options
![Genetic testing of GCK-MODY identifies a novel pathogenic variant in a Chinese boy with early onset hyperglycemia | Human Genome Variation Genetic testing of GCK-MODY identifies a novel pathogenic variant in a Chinese boy with early onset hyperglycemia | Human Genome Variation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41439-020-0096-0/MediaObjects/41439_2020_96_Fig1_HTML.png)
Genetic testing of GCK-MODY identifies a novel pathogenic variant in a Chinese boy with early onset hyperglycemia | Human Genome Variation
![A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | SpringerLink A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-018-4728-6/MediaObjects/125_2018_4728_Fig1_HTML.png)
A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | SpringerLink
![Frontiers | Modeling Maturity Onset Diabetes of the Young in Pluripotent Stem Cells: Challenges and Achievements Frontiers | Modeling Maturity Onset Diabetes of the Young in Pluripotent Stem Cells: Challenges and Achievements](https://www.frontiersin.org/files/Articles/622940/fendo-12-622940-HTML/image_m/fendo-12-622940-g001.jpg)